Optellum is attending the 2022 ASCO Annual Meeting in Chicago along with our partners from GE Healthcare. At this year’s ASCO 2022 annual meeting, GE Healthcare will demonstrate how a collection of strategic…
Optellum is referenced within the report with recommendations on how AI will be implemented and physicians trained in new technologies across the NHS Optellum has been named as one of…
Vanderbilt University Hospital Medical Center (VUMC) is the first hospital in Tennessee to introduce Optellum's Virtual Nodule Clinic. The world-leading hospital was one of the first to conduct clinical trials…
Oxford, UK/Chalfont St Giles 26 November 2021 13:00 GMT - GE Healthcare and Optellum today announced that they have signed a letter of intent to collaborate to advance precision diagnosis…
Rapidly growing lung health startup aims to redefine early interception of lung cancer using artificial intelligence (AI) decision support software. OXFORD, UK / HOUSTON, USA – August 18, 2021: Optellum,…
A new artificial intelligence software that will help doctors to make quicker and more accurate decisions when diagnosing potentially cancerous lung lesions, has received major government funding. This is a…
A paper published in Lung Cancer demonstrates the ability of Optellum’s Lung Cancer Prediction artificial intelligence (AI) to classify lung nodule malignancy. As discussed in earlier news stories, there has…
Professor Sam Janes, a leading clinician and University College London academic will presenting a poster to American Society of Clinical Oncology (ASCO) annual meeting on identifying adenocarcinoma with AI. Collaborators include Vanderbilt University Medical Center,…
Join us on June 23rd at 1pm EST for a webinar where expert clinical speakers will discuss the evidence, clinically-validated in multi center studies, and a case study in implementation…
The National Consortium of Intelligent Medical Imaging (NCIMI) podcast provides expert insights on the future of #AI in healthcare. In episode six CEO Dr Claire Bloomfield speaks to Optellum CEO…
Oxford-based company Optellum, supported by NHS collaborations and grant funding, launches the world’s first AI decision support for early lung cancer • Ground-breaking machine-learning neural network can recognise the signs…
Optellum is excited to be working with a leading hospital on the first clinical installation of Virtual Nodule Clinic (VNC). Over the past 8 months, Optellum's Virtual Nodule Clinic (VNC)…